Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1223-1230

  Roberts, Michelle R ^a,b   Shields, Peter G ^c   Ambrosone, Christine B ^b   Nie, Jing ^a   Marian, Catalin ^c   Krishnan, Shiva S ^c   Goerlitz, David S ^c   Modali, Ramakrishna ^d   Seddon, Michael ^d   Lehman, Teresa ^d   Amend, Kandace L ^e   Trevisan, Maurizio ^f   Edge, Stephen B ^b   Freudenheim, Jo L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d BioServe Biotechnologies Ltd   (United States)

^e I3 Drug Safety   (United States)

^f UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DNA; DNA BINDING PROTEIN; EXCISION REPAIR CROSS COMPLEMENTING RODENT REPAIR DEFICIENCY COMPLEMENT GROUP 4 PROTEIN; UNCLASSIFIED DRUG; X RAY REPAIR COMPLEMENTING DEFECTIVE REPAIR IN CHINESE HAMSTER CELL 1 PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 79961186635     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr096     Document Type: Article

References (70)

1. De Latt,W.L. et al. (1999) Molecular mechanisms of nucleotide excision repair. Genes Dev., 13, 768-785.
2. Gorbunova,V. et al. (2007) Changes in DNA repair during aging. Nucleic Acids Res., 35, 7466-7474.
3. Brookman,K.W. et al. (1996) ERCC4 (XPF) encodes a human nucleotide excision repair protein with eukaryotic recombination homologs. Mol. Cell. Biol., 16, 6553-6562.
4. Ciccia,A. et al. (2008) Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem., 77, 259-287.
5. Shore,R.E. et al. (2008) Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int. J. Cancer, 122, 2101-2105.
6. Sugasawa,K. et al. (1998) Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell, 2, 223-232.
7. Caldecott,K.W. (2003) XRCC1 and DNA strand break repair. DNA Repair (Amst), 2, 955-969.
8. Caldecott,K.W. (2003) Protein-protein interactions during mammalian DNA single-strand break repair. Biochem. Soc. Trans., 31, 247-251.
9. Hung,R.J. et al. (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol., 162, 925-942.
10. Zhu,Y. et al. (2008) Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. DNA Repair (Amst), 7, 141-148.
11. Dherin,C. et al. (1999) Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1 (Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res., 27, 4001-4007.
12. Janssen,K. et al. (2001) DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat. Res., 486, 207-216.
13. Vodicka,P. et al. (2007) Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis, 28, 657-664.
14. Au,W.W. et al. (2003) Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect., 111, 1843-1850.
15. Thompson,L.H. et al. (2001) Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res., 477, 131-153.
16. Thompson,P.A. et al. (2002) Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ. Mol. Mutagen., 39, 134-142.
17. Santella,R.M. et al. (2000) Immunohistochemical analysis of polycyclic aromatic hydrocarbon-DNA adducts in breast tumor tissue. Cancer Lett., 154, 143-149.
18. Gammon,M.D. et al. (2004) Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch. Environ. Health, 59, 640-649.
19. Gammon,M.D. et al. (2002) Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol. Biomarkers Prev., 11, 677-685.
20. Rundle,A. et al. (2000) The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol. Biomarkers Prev., 9, 1079-1085.
21. el-Bayoumy,K. et al. (1995) Comparative tumorigenicity of benzo[a]pyrene, 1-nitropyrene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine administered by gavage to female CD rats. Carcinogenesis, 16, 431-434.
22. Stampfer,M.R. et al. (1981) Metabolism of benzo[a]pyrene by human mammary epithelial cells: toxicity and DNA adduct formation. Proc. Natl Acad. Sci. USA, 78, 6251-6255.
23. Brooks,P.J. et al. (2005) DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol, 35, 187-193.
24. Singletary,K.W. et al. (2004) Ethanol inhibits benzo(a)pyrene DNA adduct removal and increases 8-oxo-deoxy-guanosine formation in human mammary epithelial cells. Cancer Lett., 203, 139-144.
25. Duffy,C.M. et al. (2009) Alcohol and folate intake and breast cancer risk in the WHI Observational Study. Breast Cancer Res. Treat, 116, 551-562.
26. Hamajima,N. et al. (2002) Alcohol, tobacco, and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br. J. Cancer, 87, 1234-1245.
27. Rohan,T.E. et al. (2000) Alcohol consumption and risk of breast cancer: a cohort study. Cancer Causes Control, 11, 239-247.
28. Smith-Warner,S.A. (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA, 279, 535-540.
29. Ali,M.F. et al. (2008) Prevalence of BER gene polymorphisms in sporadic breast cancer. Oncol. Rep., 19, 1033-1038.
30. Figueiredo,J.C. et al. (2004) Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol. Biomarkers Prev., 13, 583-591.
31. Sangrajrang,S. et al. (2008) Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res. Treat., 111, 279-288.
32. Smith,T.R. et al. (2003) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 12, 1200-1204.
33. Smith,T.R. et al. (2003) Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett., 190, 183-190.
34. Brewster,A.M. et al. (2006) Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res. Treat., 95, 73-80.
35. Haiman,C.A. et al. (2008) Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations. Hum. Mol. Genet., 17, 825-834.
36. Loizidou,M.A. et al. (2009) DNA -repair genetic polymorphisms and risk of breast cancer in Cyprus. Breast Cancer Res. Treat, 115, 623-627.
37. Loizidou,M.A. et al. (2008) Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res. Treat, 112, 575-579.
38. Manuguerra,M. et al. (2006) XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am. J. Epidemiol., 164, 297-302.
39. Shu,X.O. et al. (2003) A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 12, 1462-1467.
40. Thyagarajan,B. et al. (2006) No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. Cancer Detect. Prev., 30, 313-321.
41. Vogel,U. et al. (2003) No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 12, 170-171.
42. Zhang,Y. et al. (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 15, 353-358.
43. Metsola,K. et al. (2005) XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res., 7, R987-R997.
44. Bernard-Gallon,D. et al. (2008) DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol. Cancer, 7, 36.
45. Shen,J. et al. (2008) Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. Eur. J. Cancer, 44, 710-717.
46. Freudenheim,J.L. et al. (2003) Lung cancer in humans is not associated with lifetime total alcohol consumption or with genetic variation in alcohol dehydrogenase 3 (ADH3). J. Nutr., 133, 3619-3624.
47. McCann,S.E. et al. (2004) Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol. Biomarkers Prev., 13, 1480-1484.
48. McCann,S.E. et al. (2003) Alcoholic beverage preference and characteristics of drinkers and nondrinkers in western New York (United States). Nutr. Metab. Cardiovasc. Dis., 13, 2-11.
49. Russell,M. et al. (1997) Test-retest reliability of the cognitive lifetime drinking history. Am. J. Epidemiol., 146, 975-981.
50. Quick,S.K. et al. (2008) Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 17, 1082-1087.
51. Tao,M.H. et al. (2009) DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol. Biomarkers Prev., 18, 998-1002.
52. Huang,Y. et al. (2009) XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis, 24, 331-339.
53. Li,H. et al. (2009) XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast, 18, 183-191.
54. Saadat,M. et al. (2009) Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res. Treat., 115, 137-144.
55. Saadat,M. et al. (2008) Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study. Breast Cancer Res. Treat., 111, 549-553.
56. Silva,S.N. et al. (2007) Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detect. Prev., 31, 303-309.
57. Sak,S.C. et al. (2006) Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 2537-2541.
58. Lee,S.A. et al. (2005) Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp. Mol. Med., 37, 86-90.
59. Abbasi,R. et al. (2009) Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int. J. Cancer, 125, 1431-1439.
60. Sugimura,T. et al. (2006) Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J. Oral Pathol. Med., 35, 11-18.
61. Rebbeck,T.R. et al. (2004) Assessing the function of genetic variants in candidate gene association studies. Nat. Rev. Genet., 5, 589-597.
62. Hunt,R. et al. (2009) Silent (synonymous) SNPs: should we care about Them?. In Anton,A.K. (ed.) Single Nucleotide Polymorphisms: Methods in Molecular Biology. 2nd edn, Vol. 578. part 1, Humana Press, New York, NY, pp 23-39.
63. Zondervan,K.T. et al. (2007) Designing candidate gene and genome-wide case-control association studies. Nat. Protoc., 2, 2492-2501.
64. Le Marchand,L. et al. (2008) Design considerations for genomic association studies: importance of gene-environment interactions. Cancer Epidemiol. Biomarkers Prev., 17, 263-267.
65. Jorgensen,T.J. et al. (2009) Hypothesis-driven candidate gene association studies: practical design and analytical considerations. Am. J. Epidemiol., 170, 986-993.
66. Hu,J.J. et al. (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis, 22, 917-922.
67. Rowe,B.P. et al. (2010) Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Res., 12, 203.
68. Zhu,Y. et al. (2009) Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance. Cancer Treat. Rev., 35, 590-596.
69. Giovannucci,E. et al. (1993) Recall and selection bias in reporting past alcohol consumption among breast cancer cases. Cancer Causes Control, 4, 441-448.
70. Friedenreich,C.M. et al. (1991) An investigation of recall bias in the reporting of past food intake among breast cancer cases and controls. Ann. Epidemiol., 1, 439-453.